Ahmed Salah1*
Hanafy Hafez1,2
Samah Semary1,3*†
Eman Naguib Khorshed4,5Sonia Soliman6,7Iman Zaky8,7
Shahenda M. Shahin9
Leslie Lehmann10
Alaa ElHaddad1,2- 1Department of Pediatric Oncology, Children’s Cancer Hospital (57357), Cairo, Egypt
- 2Department of Pediatric Oncology, National Cancer Institute, Cairo, Egypt
- 3Department of Clinical Oncology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
- 4Department of Surgical Pathology, Children’s Cancer Hospital (57357), Cairo, Egypt
- 5Department of Surgical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
- 6Department of Clinical Pathology, Children’s Cancer Hospital (57357), Cairo, Egypt
- 7Department of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
- 8Department of Radio-diagnosis, Children’s Cancer Hospital (57357), Cairo, Egypt
- 9Department of Clinical Research, Children’s Cancer Hospital (57357), Cairo, Egypt
- 10Department of Pediatric Oncology, Dana- Farber Cancer Institute, Boston, MA, United States
A Corrigendum on
Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by Salah A, Hafez H, Semary S, Nageb E, Soliman S, Zaky I, Shahin SM, Lehmann L and ElHaddad A (2025). Front. Oncol. 15:1569370. doi: 10.3389/fonc.2025.1569370
In the published article, an author name was incorrectly written as “Eman Nageb”. The correct spelling is “Eman Naguib” Khorshed.
In the published article, Supplementary Figures were mistakenly not included in the publication. The missing Supplementary Figures have been uploaded.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CD3, Survival, Pediatric Anaplastic Large Cell Lymphoma, ALK, Outcome
Citation: Salah A, Hafez H, Semary S, Khorshed EN, Soliman S, Zaky I, Shahin SM, Lehmann L and ElHaddad A (2025) Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma. Front. Oncol. 15:1630885. doi: 10.3389/fonc.2025.1630885
Received: 18 May 2025; Accepted: 23 May 2025;
Published: 12 June 2025.
Edited and Reviewed by:
Jeffrey J. Pu, Upstate Medical University, United StatesCopyright © 2025 Salah, Hafez, Semary, Khorshed, Soliman, Zaky, Shahin, Lehmann and ElHaddad. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ahmed Salah, YWhtZWQub2JlaWRANTczNTcub3Jn; Samah Semary, U2FtYWguU2VtYXJ5QDU3MzU3Lm9yZw==
†ORCID: Samah Semary, orcid.org/0000-0002-5394-3307